Company intelligence / Profile preview

Amplexd Therapeutics

Gaithersburg, Maryland, United Statesamplexd.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Amplexd has completed promising preclinical studies for two non-invasive therapies for CIN treatment and secured $2 million in funding to finalize development and IND submissions ahead of first-in-human clinical trials[1][2][3]

Therapeutic areas: OncologyWomen's Health
Modalities: Topical therapiesPhotodynamic therapy (PDT)
Industry: Biotech

Drug pipeline

2 assets

epigallocatechin gallate

Pre-clinical

Indications: Low-grade cervical intraepithelial neoplasia

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Amplexd Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amplexd Therapeutics.

Explore the full profile